{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:06:51Z","timestamp":1790352411679,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG KA724"],"award-info":[{"award-number":["DFG KA724"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.phymed.2023.155274","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T06:16:17Z","timestamp":1702361777000},"page":"155274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Artesunate in glioblastoma therapy: Case reports and review of clinical studies"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1344-7499","authenticated-orcid":false,"given":"Herwig","family":"Strik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8217-0809","authenticated-orcid":false,"given":"Bernd","family":"Kaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2023.155274_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162588","article-title":"Abrogation of cellular senescence induced by Temozolomide in Glioblastoma cells: search for Senolytics","volume":"11","author":"Beltzig","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2023.155274_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092233","article-title":"Senescence is the main trait induced by Temozolomide in Glioblastoma cells","volume":"14","author":"Beltzig","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.phymed.2023.155274_bib0003","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1158\/1535-7163.MCT-11-0534","article-title":"Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM\/ATR damage response in cancer cells","volume":"10","author":"Berdelle","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.phymed.2023.155274_bib0004","first-page":"1599","article-title":"Artesunate in the treatment of metastatic uveal melanoma\u2013first experiences","volume":"14","author":"Berger","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.phymed.2023.155274_bib0005","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0891-5849(96)00508-4","article-title":"Artemisinin enhances heme-catalysed oxidation of lipid membranes","volume":"22","author":"Berman","year":"1997","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.phymed.2023.155274_bib0006","doi-asserted-by":"crossref","first-page":"67235","DOI":"10.18632\/oncotarget.11972","article-title":"Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence","volume":"7","author":"Berte","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2023.155274_bib0007","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/CAD.0000000000000089","article-title":"Artesunate induces G2\/M cell cycle arrest through autophagy induction in breast cancer cells","volume":"25","author":"Chen","year":"2014","journal-title":"Antican. Drugs"},{"key":"10.1016\/j.phymed.2023.155274_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-023-04387-3","article-title":"Cellular senescence in glioma","volume":"164","author":"Chojak","year":"2023","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.phymed.2023.155274_bib0009","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.01277-10","article-title":"Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain","volume":"55","author":"Clemmer","year":"2011","journal-title":"Antimicrob. Agents Chemother"},{"issue":"3","key":"10.1016\/j.phymed.2023.155274_bib65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","article-title":"A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies","volume":"81","author":"Deeken","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phymed.2023.155274_bib0010","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.bcp.2004.08.021","article-title":"Inhibition of angiogenesis in vivo and growth of Kaposi\u2019s sarcoma xenograft tumors by the anti-malarial artesunate","volume":"68","author":"Dell\u2019Eva","year":"2004","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.phymed.2023.155274_bib0011","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular senescence promotes adverse effects of chemotherapy and cancer relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Disc."},{"key":"10.1016\/j.phymed.2023.155274_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113691","article-title":"Lower dose of metformin combined with artesunate induced autophagy-dependent apoptosis of glioblastoma by activating ROS-AMPK-mTOR axis","volume":"430","author":"Ding","year":"2023","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.phymed.2023.155274_bib0013","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drup.2005.04.003","article-title":"Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy","volume":"8","author":"Efferth","year":"2005","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.phymed.2023.155274_bib0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2017.03.019","article-title":"Cancer combination therapies with artemisinin-type drugs","volume":"139","author":"Efferth","year":"2017","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.phymed.2023.155274_bib0015","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.phymed.2023.155274_bib0016","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer","volume":"18","author":"Efferth","year":"2001","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.phymed.2023.155274_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/bcmd.1996.0002","article-title":"Anti-Fas\/Apo-1 monoclonal antibody CH-11 depletes glutathione and kills multidrug-resistant human leukemic cells","volume":"22","author":"Efferth","year":"1996","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.phymed.2023.155274_bib0018","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1158\/1535-7163.MCT-07-0073","article-title":"Phytochemistry and pharmacogenomics of natural products derived from traditional Chinese medicine and Chinese materia medica with activity against tumor cells","volume":"7","author":"Efferth","year":"2008","journal-title":"Mol. Cancer Ther"},{"key":"10.1016\/j.phymed.2023.155274_bib0019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","article-title":"Toxicity of the antimalarial artemisinin and its dervatives","volume":"40","author":"Efferth","year":"2010","journal-title":"Crit. Rev. Toxicol"},{"key":"10.1016\/j.phymed.2023.155274_bib0020","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bcp.2003.12.035","article-title":"Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774","volume":"67","author":"Efferth","year":"2004","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.phymed.2023.155274_bib0021","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00204-016-1810-z","article-title":"Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature","volume":"91","author":"Efferth","year":"2017","journal-title":"Arch. Toxicol"},{"key":"10.1016\/j.phymed.2023.155274_bib0022","doi-asserted-by":"crossref","first-page":"517","DOI":"10.18632\/oncoscience.160","article-title":"Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells","volume":"2","author":"Eling","year":"2015","journal-title":"Oncoscience"},{"issue":"12","key":"10.1016\/j.phymed.2023.155274_bib61","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00228-014-1754-2","article-title":"Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer","volume":"70","author":"Ericsson","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phymed.2023.155274_bib0023","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.3390\/ijms23158171","article-title":"Exploring the mechanism of adjuvant treatment of glioblastoma using temozolomide and metformin","volume":"23","author":"Feng","year":"2022","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.phymed.2023.155274_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104484","article-title":"Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence","volume":"90","author":"Fuentes-Fayos","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phymed.2023.155274_bib63","first-page":"4417","article-title":"First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers","volume":"31","author":"Jansen","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phymed.2023.155274_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/18715206113136660340","article-title":"Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines","volume":"14","author":"Karpel-Massler","year":"2014","journal-title":"Anti-Cancer Agents Med. Chem"},{"issue":"2","key":"10.1016\/j.phymed.2023.155274_bib60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00280-016-2960-7","article-title":"Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study","volume":"77","author":"K\u00f6nig","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2023.155274_bib62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer","volume":"2","author":"Krishna","year":"2014","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phymed.2023.155274_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2023.26.e4","article-title":"Canine as a comparative and translational model for human mammary tumor","volume":"26","author":"Kwon","year":"2023","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.phymed.2023.155274_bib0027","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3835(94)03716-V","article-title":"Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin","volume":"91","author":"Lai","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1016\/j.phymed.2023.155274_bib0028","doi-asserted-by":"crossref","first-page":"56713","DOI":"10.18632\/oncotarget.10723","article-title":"Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy","volume":"7","author":"Lemke","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2023.155274_bib0029","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1158\/0008-5472.CAN-07-2970","article-title":"Artesunate derived from traditional Chinese medicine induces DNA damage and repair","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.phymed.2023.155274_bib0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4269\/ajtmh.2006.75.817","article-title":"The evaluation of radiolabeled artesunate on tissue distribution in rats and protein binding in humans","volume":"75","author":"Li","year":"2006","journal-title":"Am J. Trop. Med. Hygiene"},{"key":"10.1016\/j.phymed.2023.155274_bib0031","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00204-016-1915-4","article-title":"Comments regarding \"Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature\"","volume":"91","author":"Lu","year":"2017","journal-title":"Arch. Toxicol"},{"key":"10.1016\/j.phymed.2023.155274_bib0032","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.37.5.1108","article-title":"Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)","volume":"37","author":"Meshnick","year":"1993","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.phymed.2023.155274_bib0033","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.phymed.2015.11.001","article-title":"Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma","volume":"22","author":"Michaelsen","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2023.155274_bib0034","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1475-2875-10-263","article-title":"Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration","volume":"10","author":"Morris","year":"2011","journal-title":"Malaria J."},{"key":"10.1016\/j.phymed.2023.155274_bib0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.phymed.2018.06.002","article-title":"The activity of Artemisia spp. and their constituents against Trypanosomiasis","volume":"47","author":"Nass","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2023.155274_bib0036","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s12276-023-00977-3","article-title":"Comparative oncology: overcoming human cancer through companion animal studies","volume":"55","author":"Oh","year":"2023","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.phymed.2023.155274_bib0037","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2023.155274_bib0038","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS Statistical Report: primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro. Oncol"},{"key":"10.1016\/j.phymed.2023.155274_bib0039","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ana.20620","article-title":"Toxic brainstem encephalopathy after artemisinin treatment for breast cancer","volume":"58","author":"Panossian","year":"2005","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.phymed.2023.155274_bib0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.radonc.2012.03.018","article-title":"A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin","volume":"103","author":"Reichert","year":"2012","journal-title":"Radiother. Oncol"},{"key":"10.1016\/j.phymed.2023.155274_bib0041","first-page":"1819","article-title":"Safety and efficacy field study of artesunate for dogs with non-resectable tumours","volume":"33","author":"Rutteman","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.phymed.2023.155274_bib0042","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2016.02.017","article-title":"Antischistosomal activity of artemisinin derivatives in vivo and in patients","volume":"110","author":"Saeed","year":"2016","journal-title":"Pharmacol. Res"},{"key":"10.1016\/j.phymed.2023.155274_bib0043","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1534735406295311","article-title":"Case report of a pituitary macroadenoma treated with artemether","volume":"5","author":"Singh","year":"2006","journal-title":"Integr. Cancer Ther"},{"key":"10.1016\/j.phymed.2023.155274_bib0044","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jphs.2022.01.007","article-title":"Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells","volume":"148","author":"Song","year":"2022","journal-title":"J. Pharmacol. Sci"},{"key":"10.1016\/j.phymed.2023.155274_bib0045","first-page":"337","article-title":"Effects of artesunate on cytokinesis and G(2)\/M cell cycle progression of tumour cells and budding yeast","volume":"7","author":"Steinbruck","year":"2010","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.phymed.2023.155274_bib0046","first-page":"863","article-title":"Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas","volume":"1","author":"Strik","year":"2008","journal-title":"Molec. Med. Rep"},{"key":"10.1016\/j.phymed.2023.155274_bib0047","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11910-012-0262-y","article-title":"Temozolomide dosing regimens for glioma patients","volume":"12","author":"Strik","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep"},{"key":"10.1016\/j.phymed.2023.155274_bib0048","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl. J. Med"},{"issue":"1","key":"10.1016\/j.phymed.2023.155274_bib66","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ygyno.2019.12.035","article-title":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3)","volume":"157","author":"Trimble","year":"2020","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.phymed.2023.155274_bib0049","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-A gift from traditional Chinese medicine to the world (Nobel Lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl"},{"key":"10.1016\/j.phymed.2023.155274_bib0050","first-page":"366","article-title":"Studies on the constituents of Artemisia annual","volume":"16","author":"Tu","year":"1981","journal-title":"Acta Pharm. Sin"},{"key":"10.1016\/j.phymed.2023.155274_bib0051","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fonc.2016.00204","article-title":"Fatal liver and bone marrow toxicity by combination treatment of dichloroacetate and artesunate in a glioblastoma multiforme patient: case report and review of the literature","volume":"6","author":"Uhl","year":"2016","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.phymed.2023.155274_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"Von Hagens","year":"2017","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.phymed.2023.155274_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phymed.2018.09.178","article-title":"Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33\/2)","volume":"54","author":"Von Hagens","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2023.155274_bib0052","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a society for neuro-oncology (SNO) and European society of neuro-oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.phymed.2023.155274_bib0053","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1534735408330714","article-title":"Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model","volume":"8","author":"Wu","year":"2009","journal-title":"Integr. Cancer Ther"},{"key":"10.1016\/j.phymed.2023.155274_bib0054","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3736\/jcim20080206","article-title":"Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial","volume":"6","author":"Zhang","year":"2008","journal-title":"J. Chinese Int. Med"},{"key":"10.1016\/j.phymed.2023.155274_bib0055","first-page":"186","article-title":"Distribution and excretion of artesunate in rats","volume":"4","author":"Zhao","year":"1989","journal-title":"Proc. Chinese Acad. Medical Sci. Peking Union Medical College"},{"key":"10.1016\/j.phymed.2023.155274_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109273","article-title":"Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells","volume":"331","author":"Zhou","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.phymed.2023.155274_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.596697","article-title":"Safety and efficacy of adjunctive therapy with artesunate in the treatment of severe malaria: a systematic review and meta-analysis","volume":"11","author":"Zou","year":"2020","journal-title":"Front. Pharmacol"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323006323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711323006323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:59:12Z","timestamp":1760554752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711323006323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":65,"alternative-id":["S0944711323006323"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2023.155274","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate in glioblastoma therapy: Case reports and review of clinical studies","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2023.155274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155274"}}